Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Skin Problems & Treatments Health Center

Font Size

FDA OKs Tighter Controls for Accutane

'iPLEDGE' Program Aims to Prevent Use of Acne Drug During Pregnancy

Doctors, Patients, Pharmacies Must Register

Doctors, pharmacies, and wholesalers must also register with iPLEDGE and take on certain duties.

For instance, the prescribing doctor must counsel patients about the drug's risks, give them an informed consent form, register with iPLEDGE, note patients taking the drug in the iPLEDGE system, and receive patients' pregnancy test results.

Pharmacies must log on to iPLEDGE and check that everything is in order before filling a prescription for the drug for women of childbearing age.

Wholesale companies must agree only to give the drug to pharmacies that register with iPLEDGE.

Close Monitoring

The drug companies behind iPLEDGE have pledged to watch the system closely. Pharmacies that don't comply could be cut off from receiving the drug, and the drug's Internet availability will also be monitored, says Kweder.

All four companies making the drug -- plus one distributor -- are involved in iPLEDGE, says Kweder. Those companies include:

  • Roche, manufacturer of Accutane.
  • Genpharm, manufacturer of Amnesteem, which is distributed by Mylan/Bertek.
  • Ranbaxy Pharmaceuticals, manufacturer of Sotret.
  • Barr Laboratories, manufacturer of Claravis.

Any companies that start making other generic versions of the drug must join iPLEDGE, says Kweder.

Changes to Drug's Psychiatric Notes

Accutane and generic versions of the drug may cause depression, psychosis, and, rarely, suicidal thinking, suicide attempts, suicide, and aggressive and/or violent behaviors. However a small study earlier this year failed to show a link between the drug to severe depression or suicide.

The FDA has approved changes to the drug's existing warnings, patient information, and informed consent. The goal is to help patients and prescribers "better identify and manage the risks of psychiatric symptoms and depression before or after prescribing isotretinoin," states the FDA's news release.

"The specific intent of the iPLEDGE program is to prevent pregnancy, but this is a drug that has a number of potential side effects including the concern about psychiatric effects, but others as well. The intent is that patients be educated about all of the potential risks as part of their participation in taking the medicine," says Kweder.

Today on WebMD

Pictures and symptoms of the red, scaly rash.
woman with dyed dark hair
What it says about your health.
woman with cleaning products
Top causes of the itch that rashes.
atopic dermatitus
Identify and treat common skin problems.
itchy skin
shingles rash on skin
woman with skin tag
Woman washing face
woman washing her hair in sink
close up of womans bare neck
woman with face cream